Cargando…
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Autores principales: | Freedberg, Daniel E., Conigliaro, Joseph, Wang, Timothy C., Tracey, Kevin J., Callahan, Michael V., Abrams, Julian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242191/ https://www.ncbi.nlm.nih.gov/pubmed/32446698 http://dx.doi.org/10.1053/j.gastro.2020.05.053 |
Ejemplares similares
-
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
por: Janowitz, Tobias, et al.
Publicado: (2020) -
Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized Patients With Coronavirus Disease 2019 From a Large Healthcare System
por: Yeramaneni, Samrat, et al.
Publicado: (2021) -
Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank
por: Fan, Xiude, et al.
Publicado: (2021) -
Hospitalization risk among patients with Mpox infection—a propensity score matched analysis
por: Henao-Martínez, Andrés F., et al.
Publicado: (2023)